Advertisement
Advertisement
AVNS
Avanos Medical, Inc.
14.58
USDSponsored
+0.73
+5.29%
Feb 06, 16:00 UTC -5
Closed
After-Market
14.57
-0.01
-0.05%
AVNS Earnings Reports
Positive Surprise Ratio
AVNS beat 29 of 40 last estimates.
73%
Next Report
Date of Next Report
Feb 24, 2026
Estimate for Q4 25 (Revenue/ EPS)
$178.19M
/$0.25
Implied change from Q3 25 (Revenue/ EPS)
+0.22%
/+13.64%
Implied change from Q4 24 (Revenue/ EPS)
-0.78%
/-40.48%
Avanos Medical, Inc. earnings per share and revenue
On Nov 05, 2025, AVNS reported earnings of 0.22 USD per share (EPS) for Q3 25, beating the estimate of 0.12 USD, resulting in a 79.74% surprise. Revenue reached 177.80 million, compared to an expected 167.79 million, with a 5.97% difference. The market reacted with a -5.66% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 3 analysts forecast an EPS of 0.25 USD, with revenue projected to reach 178.19 million USD, implying an increase of 13.64% EPS, and increase of 0.22% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
What were Avanos Medical, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Avanos Medical, Inc. reported EPS of $0.22, beating estimates by 79.74%, and revenue of $177.80M, 5.97% above expectations.
How did the market react to Avanos Medical, Inc.'s Q3 2025 earnings?
The stock price moved down -5.66%, changed from $11.30 before the earnings release to $10.66 the day after.
When is Avanos Medical, Inc. expected to report next?
The next earning report is scheduled for Feb 24, 2026.
What are the forecasts for Avanos Medical, Inc.'s next earnings report?
Based on 3
analysts, Avanos Medical, Inc. is expected to report EPS of $0.25 and revenue of $178.19M for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement